{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:49:19Z","timestamp":1769604559348,"version":"3.49.0"},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4873","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T07:46:35Z","timestamp":1567755995000},"source":"Crossref","is-referenced-by-count":6,"title":["Selective uveal melanoma inhibition with calcium channel blockade"],"prefix":"10.3892","author":[{"given":"Michael","family":"Shaughnessy","sequence":"first","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Lamuraglia","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Klebanov","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Ji","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anpuchchelvi","family":"Rajadurai","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Flaherty","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Center for Melanoma, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hensin","family":"Tsao","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2605, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"key20200713190042_b1-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"key20200713190042_b2-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: From diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"key20200713190042_b3-ijo-55-05-1090","first-page":"14","article-title":"Clinical and therapeutic implications of melanoma genomics","volume":"2","author":"Shaughnessy","year":"2018","journal-title":"J Transl Genet Genom"},{"key":"key20200713190042_b4-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","article-title":"Incidence of uveal melanoma in the United States: 1973-1997","volume":"110","author":"Singh","year":"2003","journal-title":"Ophthalmology"},{"key":"key20200713190042_b5-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: Relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond)"},{"key":"key20200713190042_b6-ijo-55-05-1090","doi-asserted-by":"crossref","DOI":"10.15586\/codon.noncutaneousmelanoma.2018.ch1","article-title":"Uveal melanoma","volume-title":"Noncutaneous melanoma","author":"Grisanti","year":"2018"},{"key":"key20200713190042_b7-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cncr.11113","article-title":"A prognostic model and staging for metastatic uveal melanoma","volume":"97","author":"Eskelin","year":"2003","journal-title":"Cancer"},{"key":"key20200713190042_b8-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"key":"key20200713190042_b9-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","article-title":"Effectiveness of treatments for metastatic uveal melanoma","volume":"148","author":"Augsburger","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"key20200713190042_b10-ijo-55-05-1090","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.4362.x","article-title":"Adjuvant intravenous therapy by fotemustine in uveal melanoma: A randomised study","author":"Desjardins","year":"2011","journal-title":"Acta Ophthalmologica"},{"key":"key20200713190042_b11-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11912-017-0606-5","article-title":"Immunotherapy for the treatment of uveal melanoma: Current status and emerging therapies","volume":"19","author":"Komatsubara","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"key20200713190042_b12-ijo-55-05-1090","first-page":"1230","article-title":"Ocular melanoma: An overview of the current status","volume":"6","author":"Jovanovic","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200713190042_b13-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1016\/j.bbamem.2014.08.016","article-title":"Altered calcium signaling in cancer cells","volume":"1848","author":"Stewart","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key20200713190042_b14-ijo-55-05-1090","first-page":"12","article-title":"The multi-functional calcium\/calmodulin stimulated protein kinase (CaMK) family: Emerging targets for anti-cancer therapeutic intervention","volume-title":"Pharmaceuticals (Basel)","author":"Brzozowski","year":"2019"},{"key":"key20200713190042_b15-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2016.11.001","article-title":"Targeting calcium signaling in cancer therapy","volume":"7","author":"Cui","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"key20200713190042_b16-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/carcin\/bgy188","article-title":"Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival","volume":"40","author":"Wang","year":"2019","journal-title":"Carcinogenesis"},{"key":"key20200713190042_b17-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.trecan.2017.01.007","article-title":"Calmodulin and PI3K signaling in KRAS cancers","volume":"3","author":"Nussinov","year":"2017","journal-title":"Trends Cancer"},{"key":"key20200713190042_b18-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/pcmr.12690","article-title":"T-type calcium channels drive migration\/invasion in BRAFV600E melanoma cells through Snail1","volume":"31","author":"Maiques","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20200713190042_b19-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"e89292","DOI":"10.1371\/journal.pone.0089292","article-title":"Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration","volume":"9","author":"Umemura","year":"2014","journal-title":"PLoS One"},{"key":"key20200713190042_b20-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2017.04.002","article-title":"RasGRP3 mediates MAPK pathway activation in GNAQ mutant uveal melanoma","volume":"31","author":"Chen","year":"2017","journal-title":"Cancer Cell"},{"key":"key20200713190042_b21-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"e1078431","DOI":"10.1080\/21592799.2015.1078431","article-title":"Diacylglycerol kinases in membrane trafficking","volume":"5","author":"Xie","year":"2015","journal-title":"Cell Logist"},{"issue":"Suppl A","key":"key20200713190042_b22-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"A71","DOI":"10.1093\/eurheartj\/18.suppl_A.71","article-title":"Pharmacological differences between calcium antagonists","volume":"18","author":"Opie","year":"1997","journal-title":"Eur Heart J"},{"key":"key20200713190042_b23-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1755-148X.2012.00978.x","article-title":"Functional expression of voltage-gated calcium channels in human melanoma","volume":"25","author":"Das","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20200713190042_b24-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1874467208666150507105845","article-title":"Pharmacology of L-type calcium channels: Novel drugs for old targets?","volume":"8","author":"Striessnig","year":"2015","journal-title":"Curr Mol Pharmacol"},{"key":"key20200713190042_b25-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/1756-0500-5-168","article-title":"Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells","volume":"5","author":"Zou","year":"2012","journal-title":"BMC Res Notes"},{"key":"key20200713190042_b26-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"e0150460","DOI":"10.1371\/journal.pone.0150460","article-title":"Drug repositioning for cancer therapy based on large-scale drug-induced transcriptional signatures","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"key20200713190042_b27-ijo-55-05-1090","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbrc.2008.02.075","article-title":"Amlodipine inhibits cell proliferation via PKD1-related pathway","volume":"369","author":"Ohba","year":"2008","journal-title":"Biochem Biophys Res Commun"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:06:06Z","timestamp":1594667166000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4873","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]}}}